Penicillin Dosage for Adult Strep Throat
For an otherwise healthy adult with streptococcal pharyngitis, prescribe penicillin V 250 mg four times daily OR 500 mg twice daily for 10 days. 1
Recommended Dosing Regimens
The IDSA guideline provides two equivalent oral penicillin V options for adults 1:
- 250 mg four times daily for 10 days (strong recommendation, high-quality evidence)
- 500 mg twice daily for 10 days (strong recommendation, high-quality evidence)
The FDA label confirms these dosing schedules, specifying 125-250 mg every 6-8 hours for streptococcal infections of the upper respiratory tract 2.
Why Twice-Daily Dosing Is Preferred
The 500 mg twice-daily regimen is clinically superior for real-world practice because it significantly improves adherence while maintaining equivalent efficacy to more frequent dosing 3, 4, 5. Meta-analysis demonstrates that twice-daily penicillin achieves the same cure rates as three or four times daily dosing 3.
Critical Pitfall: Avoid Once-Daily Dosing
Do not prescribe penicillin V once daily - this regimen has consistently higher failure rates:
- 22% bacteriologic failure with once-daily versus 8% with three-times-daily dosing 6
- 23% recurrent positive cultures with once-daily versus 8% with twice-daily dosing 7
- Meta-analysis shows once-daily penicillin has 12 percentage points lower cure rate compared to more frequent dosing 3
Alternative First-Line Option
Amoxicillin 500 mg twice daily for 10 days is an acceptable alternative to penicillin V, particularly if adherence is a concern 1. Unlike penicillin, amoxicillin can be given once daily (1000 mg) without loss of efficacy, though this broader-spectrum agent is more expensive 1.
Duration of Therapy
The full 10-day course is mandatory to achieve maximal pharyngeal eradication of Group A Streptococcus 1. Shorter courses cannot be endorsed despite FDA approval of some agents for 5-day regimens, as these lack rigorous evidence and use broader-spectrum antibiotics 1.
Why Penicillin Remains First-Line
Penicillin V is the treatment of choice based on 1:
- Proven efficacy and safety
- Narrow antimicrobial spectrum
- Low cost
- No documented penicillin resistance in Group A Streptococcus
The goal is preventing acute rheumatic fever, suppurative complications, reducing contagiousness, and improving symptoms while minimizing unnecessary broad-spectrum antibiotic use 1.
For Penicillin-Allergic Patients
If the patient has a penicillin allergy: